An interesting read. Many years and many millions of dollars trying to bring this to market. The outcome of negative will/should put PAR in the spotlight. A positive result for them will give them a head start but our products safety history to date will put it in the preferred status
worth watching the outcome
Also should this not be successful then Pfizer and others will come knocking
dyor
research reports and media, page-1400
-
- There are more pages in this discussion • 2,997 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $81.32M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 22.0¢ | $62.99K | 277.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 530 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 24391 | 5 |
View Market Depth
| Last trade - 15.02pm 14/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |